BioCentury
ARTICLE | Clinical News

Norditropin regulatory update

November 8, 2004 8:00 AM UTC

FDA approved an expanded label for Norditropin to treat severe hormone growth hormone deficiency in adults. The somatropin recombinant growth hormone injection already is approved to treat children. ...